Literature DB >> 28087176

Carotid plaque detection improves the predictive value of CHA2DS2-VASc score in patients with non-valvular atrial fibrillation: The ARAPACIS Study.

Stefania Basili1, Lorenzo Loffredo1, Daniele Pastori1, Marco Proietti2, Alessio Farcomeni3, Anna Rita Vestri3, Pasquale Pignatelli1, Giovanni Davì4, William R Hiatt5, Gregory Y H Lip2, Gino R Corazza6, Francesco Perticone7, Francesco Violi8.   

Abstract

BACKGROUND AND AIMS: Vascular disease (VD), as assessed by history of myocardial infarction or peripheral artery disease or aortic plaque, increases stroke risk in atrial fibrillation (AF), and is a component of risk assessment using the CHA2DS2-VASc score. We investigated if systemic atherosclerosis as detected by ultrasound carotid plaque (CP) could improve the predictive value of the CHA2DS2-VASc score.
METHODS: We analysed data from the ARAPACIS study, an observational study including 2027 Italian patients with non-valvular AF, in whom CP was detected using Doppler Ultrasonography.
RESULTS: VD was reported in 351 (17.3%) patients while CP was detected in 16.6% patients. Adding CP to the VD definition leaded to higher VD prevalence (30.9%). During a median [IQR] follow-up time of 36months, 56 (2.8%) stroke/TIA events were recorded. Survival analysis showed that conventional VD alone did not increase the risk of stroke (Log-Rank: 0.009, p=0.924), while addition of CP to conventional VD was significantly associated to an increased risk of stroke (LR: 5.730, p=0.017). Cox regression analysis showed that VD+CP was independently associated with stroke (HR: 1.78, 95% CI: 1.05-3.01, p=0.0318). Reclassification analysis showed that VD+CP allowed a significant risk reclassification when compared to VD alone in predicting stroke at 36months (NRI: 0.192, 95% CI: 0.028-0.323, p=0.032).
CONCLUSIONS: In non-valvular AF patients the addition of ultrasound detection of carotid plaque to conventional VD significantly increases the predictive value of CHA2DS2-VASc score for stroke.
Copyright © 2017. Published by Elsevier B.V.

Entities:  

Keywords:  Atherosclerosis; Atrial fibrillation; CHA(2)DS(2)-VASc score; Carotid plaque; Stroke; Vascular disease

Mesh:

Year:  2017        PMID: 28087176     DOI: 10.1016/j.ijcard.2017.01.001

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  9 in total

Review 1.  Atherosclerosis and Atrial Fibrillation: Double Trouble.

Authors:  Mehran Abolbashari
Journal:  Curr Cardiol Rep       Date:  2022-01-06       Impact factor: 2.931

Review 2.  Carotid Atherosclerosis in Patients with Atrial Fibrillation.

Authors:  Zhaojia Wang; Panagiotis Korantzopoulos; Tong Liu
Journal:  Curr Atheroscler Rep       Date:  2019-11-29       Impact factor: 5.113

3.  Inflammatory activation and endothelial dysfunction markers in patients with permanent atrial fibrillation: a cross-sectional study.

Authors:  Carlo Domenico Maida; Sonya Vasto; Domenico Di Raimondo; Alessandra Casuccio; Valerio Vassallo; Mario Daidone; Alessandro Del Cuore; Gaetano Pacinella; Anna Cirrincione; Irene Simonetta; Vittoriano Della Corte; Salvatore Rizzica; Giulio Geraci; Antonino Tuttolomondo; Antonio Pinto
Journal:  Aging (Albany NY)       Date:  2020-05-03       Impact factor: 5.682

4.  The association of CHA2DS2-VASc score and carotid plaque in patients with non-valvular atrial fibrillation.

Authors:  Luxiang Shang; Yang Zhao; Mengjiao Shao; Huaxin Sun; Min Feng; Yaodong Li; Xianhui Zhou; Baopeng Tang
Journal:  PLoS One       Date:  2019-02-08       Impact factor: 3.240

5.  Impact of the Total Number of Carotid Plaques on the Outcome of Ischemic Stroke Patients with Atrial Fibrillation.

Authors:  Hyungjong Park; Minho Han; Young Dae Kim; Joonsang Yoo; Hye Sun Lee; Jin Kyo Choi; Ji Hoe Heo; Hyo Suk Nam
Journal:  J Clin Med       Date:  2019-11-07       Impact factor: 4.241

6.  Increased serum calcium levels are associated with carotid atherosclerotic plaque in normocalcaemic individuals with type 2 diabetes.

Authors:  Huijing Zhu; Huili Wang; Yuqing Jia; Lin Cheng; Xingbo Cheng
Journal:  Ther Adv Endocrinol Metab       Date:  2021-03-29       Impact factor: 3.565

7.  Effects of Lipid Lowering Therapy Optimization by PCSK9 Inhibitors on Circulating CD34+ Cells and Pulse Wave Velocity in Familial Hypercholesterolemia Subjects without Atherosclerotic Cardiovascular Disease: Real-World Data from Two Lipid Units.

Authors:  Roberto Scicali; Giuseppe Mandraffino; Michele Scuruchi; Alberto Lo Gullo; Antonino Di Pino; Viviana Ferrara; Carmela Morace; Caterina Oriana Aragona; Giovanni Squadrito; Francesco Purrello; Salvatore Piro
Journal:  Biomedicines       Date:  2022-07-15

Review 8.  A Review of Biomarkers for Ischemic Stroke Evaluation in Patients With Non-valvular Atrial Fibrillation.

Authors:  Luxiang Shang; Ling Zhang; Yankai Guo; Huaxin Sun; Xiaoxue Zhang; Yakun Bo; Xianhui Zhou; Baopeng Tang
Journal:  Front Cardiovasc Med       Date:  2021-07-01

9.  Impact of carotid atherosclerosis in CHA2DS2-VASc-based risk score on predicting ischemic stroke in patients with atrial fibrillation.

Authors:  Dong-Hyuk Cho; Jong-Il Choi; Jimi Choi; Yun Gi Kim; Suk-Kyu Oh; Hyungdon Kook; Kwang No Lee; Jaemin Shim; Seong-Mi Park; Wan Joo Shim; Young-Hoon Kim
Journal:  Korean J Intern Med       Date:  2020-02-27       Impact factor: 2.884

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.